-
4m 50sPart 2 | Session 5 Balloon-in-Basket PFA without Propofol
-
5m 58sPart 2 | Session 6 ADVENT LTO: Long-Term PFA Outcomes and AF Progression
-
4m 16sPart 3 | Session 1 4 Trials That Will Change My Practice with Dr Luigi Di Biase
-
5m 18sPart 3 | Session 2 AF & EP in 2026: Five Things That Will Change Daily Practice
-
10m 44sPart 1 | Session 1 Complication Prevention in Complex AF and VT Procedures
-
12m 35sPart 1 | Session 2 Will PFA Redefine AF Ablation Strategies in 2026?
-
9m 39sPart 1 | Session 3 Redo AF Ablation: When to Go Beyond PVI?
-
4m 10sPart 2 | Session 1 Stroke Management After AF Ablation
-
7m 20sPart 2 | Session 2 VOLT AF IDE
-
5m 53sPart 2 | Session 3 VERITAS Study: Next-Generation LAA Closure with Amulet 360
AF Symposium 2026 - Prof Roland Tilz (University Heart Center Lübeck, DE) presents updated findings from the STYLE AF study evaluating vascular closure strategies in patients undergoing atrial fibrillation ablation, with implications for procedural efficiency and same-day discharge protocols.
Results demonstrated clear superiority of the vascular closure device across multiple clinically relevant endpoints: accelerated time to hemostasis, markedly reduced time to ambulation, and faster eligibility for hospital discharge. The findings provide foundational evidence supporting same-day discharge protocols for AF ablation.
Building on this work, the ongoing SHAZAM AF study is randomizing patients to same-day discharge utilizing vascular closure devices versus traditional overnight inpatient observation. Investigators hypothesize that the same-day discharge strategy will demonstrate superiority specifically in reducing vascular access complications. Enrollment completion is anticipated in 2026, with results expected for presentation in 2027.
Recorded on-site at AF Symposium 2026.
Editors: Jordan Rance
Videographer: Oliver Miles
Support: This is an independent interview produced by Radcliffe Cardiology.
Stay up to date with our video collection covering late-breaking data from AF Symposium 2026 in Boston. Don't miss our short, accessible Expert Interviews, Discussions and Highlights of the most pertinent trials.
More from this programme
Part 1
Clinical Discussions
Part 2
Expert Interviews
Faculty Biographies
Roland R Tilz
Deputy Director
Prof Roland Tilz is the deputy director of the Medical Center II of the University Hospital in Lübeck and professor of the invasive electrophysiology at the University Lübeck. He is committed to training in the field of “Invasive electrophysiology and cardiac rhythm implants”. Prof Roland Tilz trained at the Addenbrooks Hospital in Cambridge (UK), Bedford Hospital (UK), Klinikum Bayreuth and at the Asklepios Klinik St. Georg in Hamburg.
Comments